Bionano Genomics
BNGO
$0.17
Share price
-8.16%
Change (1 day)
-87.99%
Change (1 year)
Operating Margin for Bionano Genomics (BNGO)
Operating Margin as of March 2025 (TTM): -390.90%
According to Bionano Genomics 's latest financial reports and stock price the company's current Operating Margin is -390.90%. At the end of 2023 the company had an Operating Margin of -643.57%.
Operating Margin history for Bionano Genomics from 2017 to 2024
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2023 | -643.57% | 36.88% |
| 2022 | -470.15% | 8.17% |
| 2021 | -434.64% | -10.03% |
| 2020 | -483.09% | 64.24% |
| 2019 | -294.13% | 91% |
| 2018 | -154.00% | -37.3% |
| 2017 | -245.63% | -11.42% |
| 2016 | -277.29% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 | -38.51% | -90.15% | 🇺🇸 USA |
 | -28.12% | -92.81% | 🇺🇸 USA |
 | 14.13% | -103.61% | 🇺🇸 USA |
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.